by Santiago Balza Pineda | Aug 9, 2023 | Announcement
Miami, Florida, August 9th, 2023 — Allosite Therapeutics (DBA of 149 Bio, LLC) has announced its generic name for its clinical stage, lead candidate as Ontegimod (pronounced aun-teh-gi-mod). The company recently obtained rights to this molecule as part of its...
by 149bio | Aug 8, 2023 | Announcement
Miami, FL, August 8, 2023, (AllositeTx) – 149 Bio, LLC (DBA Allosite Therapeutics), a pioneering biotechnology company, announced launch of its updated website as Allosite Therapeutics. This strategic update reflects our focus on developing innovative therapeutics...
Recent Comments